<DOC>
	<DOCNO>NCT02881112</DOCNO>
	<brief_summary>The study open-label , non-controlled study safety effectiveness investigator determine Provant therapy subject pain and/or edema various pain etiology . Information collect study enter registry database .</brief_summary>
	<brief_title>A Registry Study Evaluate Outcomes PEMF Therapy Subjects With Various Pain Etiologies</brief_title>
	<detailed_description>This open-label , non-controlled trial subject various pain etiology multiple center US . Eligible subject include â‰¥ 22 year age deem appropriate treatment Provant study investigator ( prescriber ) . Subjects treat base treatment prescribe ( location , frequency , duration ) study investigator . Data assessment administer part standard practice obtain baseline , minimum , end treatment . If investigator administers additional assessment course treatment , data collect . Safety assess office visit review AE report concomitant treatment medication . All concomitant drug non-drug treatment use study record . Information collect study enter registry database .</detailed_description>
	<criteria>1 . Subject age great equal 22 year . 2 . Subject pain ( chronic acute ) and/or edema prescriber deem treatment Provant warrant . 3 . Subject willing able give write informed consent . 4 . Female subject must postmenopausal , surgically sterile , abstinent , practicing ( agree practice ) effective method birth control sexually active duration study . ( Effective method birth control include prescription hormonal contraceptive , intrauterine device , doublebarrier method , and/or male partner sterilization ) . 1 . Subject require anticipates need surgery type duration treatment . 2 . Subject receive investigational drug device within 30 day 5 halflives drug , whichever longer , prior Screening Visit enrol another clinical trial . 3 . Subject use systemic corticosteroid within 2 month Screening Visit . 4 . Subject history solid tumor complete remission great 2 year successfully treat nonmetastatic basal cell squamous cell carcinoma skin treatment area . 5 . Subject history blood cancer ( e.g. , leukemia , lymphoma , multiple myeloma ) . 6 . Subject serious psychosocial comorbidity . 7 . Subject history drug alcohol abuse within one year prior Screening Visit . 8 . Subject implanted pacemaker , defibrillator , neurostimulator , spinal cord stimulator , bone stimulator , cochlear implant , implanted device implant metal lead ( ) . 9 . Subject currently pregnant plan become pregnant treatment period . 10 . Subject previously treat Provant Therapy System . 11 . Subject unwilling unable follow study instruction , comply treatment regimen study visit .</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>